-
1
-
-
0036156276
-
Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: Does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia?
-
Gamis AS, Hilden JM. Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia? J Pediatr Hematol Oncol. 2002;24:2-5.
-
(2002)
J Pediatr Hematol Oncol
, vol.24
, pp. 2-5
-
-
Gamis, A.S.1
Hilden, J.M.2
-
2
-
-
0026969358
-
Transient abnormal myelopoiesis in Down's syndrome
-
Kurahashi H, Hara J, Yumura-Yagi K, Tawa A, Kawa-Ha K. Transient abnormal myelopoiesis in Down's syndrome. Leuk Lymphoma. 1992;8:465-475.
-
(1992)
Leuk Lymphoma
, vol.8
, pp. 465-475
-
-
Kurahashi, H.1
Hara, J.2
Yumura-Yagi, K.3
Tawa, A.4
Kawa-Ha, K.5
-
3
-
-
0025819483
-
Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome
-
Kurahashi H, Hara J, Yumura-Yagi K, et al. Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome. Blood. 1991;77:1161-1163.
-
(1991)
Blood
, vol.77
, pp. 1161-1163
-
-
Kurahashi, H.1
Hara, J.2
Yumura-Yagi, K.3
-
4
-
-
0036156452
-
Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome
-
Holt SE, Brown EJ, Zipursky A. Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome. J Pediatr Hematol Oncol. 2002;24;14-17.
-
(2002)
J Pediatr Hematol Oncol
, vol.24
, pp. 14-17
-
-
Holt, S.E.1
Brown, E.J.2
Zipursky, A.3
-
5
-
-
0033780541
-
The management of neoplastic disorders of haematopoiesis in children with Down's syndrome
-
Lange B. The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. Br J Haematol. 2000;110:512-524.
-
(2000)
Br J Haematol
, vol.110
, pp. 512-524
-
-
Lange, B.1
-
7
-
-
0023459992
-
Megakaryoblastic leukemia and Down's syndrome: A review
-
Zipursky A, Peeters M, Poon A. Megakaryoblastic leukemia and Down's syndrome: a review. Pediatr Hematol Oncol. 1987;4:211-230.
-
(1987)
Pediatr Hematol Oncol
, vol.4
, pp. 211-230
-
-
Zipursky, A.1
Peeters, M.2
Poon, A.3
-
8
-
-
0035412104
-
Pattern of malignant disorders in individuals with Down's syndrome
-
Hasle H. Pattern of malignant disorders in individuals with Down's syndrome. Lancet Oncol. 2001;2:429-436.
-
(2001)
Lancet Oncol
, vol.2
, pp. 429-436
-
-
Hasle, H.1
-
9
-
-
0036153956
-
Down syndrome, transient myeloproliferative syndrome, and leukemia: Bridging development and neoplasia
-
Arceci RJ. Down syndrome, transient myeloproliferative syndrome, and leukemia: bridging development and neoplasia. J Pediatr Hematol Oncol. 2002;24:1
-
(2002)
J Pediatr Hematol Oncol
, vol.24
, pp. 1
-
-
Arceci, R.J.1
-
10
-
-
7844233319
-
Cytogenetic and molecular study of 32 Down syndrome families: Potential leukaemia predisposing role of the most proximal segment of chromosome 21q
-
Cavani S, Perfumo C, Argusti A, et al. Cytogenetic and molecular study of 32 Down syndrome families: potential leukaemia predisposing role of the most proximal segment of chromosome 21q. Br J Haematol. 1998;103:213-216.
-
(1998)
Br J Haematol
, vol.103
, pp. 213-216
-
-
Cavani, S.1
Perfumo, C.2
Argusti, A.3
-
11
-
-
0033991491
-
The role of p53 in megakaryocyte differentiation and the megakaryocytic leukemias of Down syndrome
-
Malkin D, Brown EJ, Zipursky A. The role of p53 in megakaryocyte differentiation and the megakaryocytic leukemias of Down syndrome. Cancer Genet Cytogenet. 2000;116:1-5.
-
(2000)
Cancer Genet Cytogenet
, vol.116
, pp. 1-5
-
-
Malkin, D.1
Brown, E.J.2
Zipursky, A.3
-
12
-
-
0036636857
-
Core-binding factors in haematopoiesis and leukaemia
-
Speck NA, Gilliland DG. Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer. 2002;2:502-513.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 502-513
-
-
Speck, N.A.1
Gilliland, D.G.2
-
13
-
-
0034667690
-
High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired tdsomy 21
-
Preudhomme C, Warot-Loze D, Roumier C, et al. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired tdsomy 21. Blood. 2000; 96:2862-2869.
-
(2000)
Blood
, vol.96
, pp. 2862-2869
-
-
Preudhomme, C.1
Warot-Loze, D.2
Roumier, C.3
-
14
-
-
0032830638
-
Haplo-insufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
-
Song WJ, Sullivan MG, Legare RD, et al. Haplo-insufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet. 1999;23:166-175.
-
(1999)
Nat Genet
, vol.23
, pp. 166-175
-
-
Song, W.J.1
Sullivan, M.G.2
Legare, R.D.3
-
15
-
-
0036736555
-
Mutation of the AML1/RUNX1 gene in a transient myeloproliferative disorder patient with Down syndrome
-
Taketani T, Taki T, Takita J, et al. Mutation of the AML1/RUNX1 gene in a transient myeloproliferative disorder patient with Down syndrome. Leukemia. 2002;16:1866-1867.
-
(2002)
Leukemia
, vol.16
, pp. 1866-1867
-
-
Taketani, T.1
Taki, T.2
Takita, J.3
-
16
-
-
17344368548
-
CBFA2, frequently rearranged in leukemia, is not responsible for a familial leukemia syndrome
-
Legare RD, Lu D, Gallagher M, et al. CBFA2, frequently rearranged in leukemia, is not responsible for a familial leukemia syndrome. Leukemia. 1997;11:2111-2119.
-
(1997)
Leukemia
, vol.11
, pp. 2111-2119
-
-
Legare, R.D.1
Lu, D.2
Gallagher, M.3
-
17
-
-
0036727413
-
Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome
-
Wechsler J, Greene M, McDevitt MA, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet. 2002;32:148-152.
-
(2002)
Nat Genet
, vol.32
, pp. 148-152
-
-
Wechsler, J.1
Greene, M.2
McDevitt, M.A.3
-
18
-
-
0037071383
-
Transcriptional regulation of erythropoiesis: An affair involving multiple partners
-
Cantor AB, Orkin SH. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene. 2002;21:3368-3376.
-
(2002)
Oncogene
, vol.21
, pp. 3368-3376
-
-
Cantor, A.B.1
Orkin, S.H.2
-
19
-
-
0032227812
-
Transcription factor GATA-1 in megakaryocyte development
-
Orkin SH, Shivdasani RA, Fujiwara Y, McDevitt MA. Transcription factor GATA-1 in megakaryocyte development. Stem Cells. 1998;16(suppl 2):79-83.
-
(1998)
Stem Cells
, vol.16
, Issue.SUPPL. 2
, pp. 79-83
-
-
Orkin, S.H.1
Shivdasani, R.A.2
Fujiwara, Y.3
McDevitt, M.A.4
-
20
-
-
0034812344
-
Molecular and transcriptional regulation of megakaryocyte differentiation
-
Shivdasani RA. Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells. 2001;19:397-407.
-
(2001)
Stem Cells
, vol.19
, pp. 397-407
-
-
Shivdasani, R.A.1
-
21
-
-
0030926006
-
A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development
-
Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 1997;16:3965-3973.
-
(1997)
EMBO J
, vol.16
, pp. 3965-3973
-
-
Shivdasani, R.A.1
Fujiwara, Y.2
McDevitt, M.A.3
Orkin, S.H.4
-
22
-
-
0037081819
-
Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation
-
Freson K, Matthijs G, Thys C, et al. Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation. Hum Mol Genet. 2002;11:147-152.
-
(2002)
Hum Mol Genet
, vol.11
, pp. 147-152
-
-
Freson, K.1
Matthijs, G.2
Thys, C.3
-
23
-
-
0034052854
-
Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1
-
Nichols KE, Crispino JD, Poncz M, et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet. 2000;24:266-270.
-
(2000)
Nat Genet
, vol.24
, pp. 266-270
-
-
Nichols, K.E.1
Crispino, J.D.2
Poncz, M.3
-
24
-
-
0037105495
-
X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction
-
Yu C, Niakan KK, Matsushita M, Stamatoyannopoulos G, Orkin SH, Raskind WH. X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood. 2002;100:2040-2045.
-
(2002)
Blood
, vol.100
, pp. 2040-2045
-
-
Yu, C.1
Niakan, K.K.2
Matsushita, M.3
Stamatoyannopoulos, G.4
Orkin, S.H.5
Raskind, W.H.6
-
25
-
-
0029558618
-
Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor
-
Calligaris R, Bottardi S, Cogoi S, Apezteguia I, Santoro C. Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor. Proc Natl Acad Sci U S A. 1995;92:11598-11602.
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, pp. 11598-11602
-
-
Calligaris, R.1
Bottardi, S.2
Cogoi, S.3
Apezteguia, I.4
Santoro, C.5
-
26
-
-
19044395448
-
Molecular analysis of the APC gene in 71 Israeli families: 17 Novel mutations
-
Gavert N, Yaron Y, Naiman T, et al. Molecular analysis of the APC gene in 71 Israeli families: 17 novel mutations. Hum Mutat. 2002;19:664.
-
(2002)
Hum Mutat
, vol.19
, pp. 664
-
-
Gavert, N.1
Yaron, Y.2
Naiman, T.3
-
27
-
-
0036841169
-
Use of denaturing HPLC to provide efficient detection of mutations causing familial hypercholesterolemia
-
Bodamer OA, Bercovich D, Schlabach M, Ballantyne C, Zoch D, Beaudet AL. Use of denaturing HPLC to provide efficient detection of mutations causing familial hypercholesterolemia. Clin Chem. 2002;48:1913-1918.
-
(2002)
Clin Chem
, vol.48
, pp. 1913-1918
-
-
Bodamer, O.A.1
Bercovich, D.2
Schlabach, M.3
Ballantyne, C.4
Zoch, D.5
Beaudet, A.L.6
-
28
-
-
0034764037
-
Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis
-
Karandikar NJ, Aquino DB, McKenna RW, Kroft SH. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis. Am J Clin Pathol. 2001;116:204-210
-
(2001)
Am J Clin Pathol
, vol.116
, pp. 204-210
-
-
Karandikar, N.J.1
Aquino, D.B.2
McKenna, R.W.3
Kroft, S.H.4
-
29
-
-
0032941980
-
Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome
-
Zipursky A, Brown EJ, Christensen H, Doyle J. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome. Clin Lab Med. 1999;19:157-167,vii.
-
(1999)
Clin Lab Med
, vol.19
, pp. 157-167
-
-
Zipursky, A.1
Brown, E.J.2
Christensen, H.3
Doyle, J.4
-
30
-
-
0036153957
-
Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study
-
Al-Kasim F, Doyle JJ, Massey GV, Weinstein HJ, Zipursky A. Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study. J Pediatr Hematol Oncol. 2002;24:9-13.
-
(2002)
J Pediatr Hematol Oncol
, vol.24
, pp. 9-13
-
-
Al-Kasim, F.1
Doyle, J.J.2
Massey, G.V.3
Weinstein, H.J.4
Zipursky, A.5
-
31
-
-
0036046660
-
Acquired trisomy 21 and distinct clonal evolution in acute megakaryoblastic leukaemia in young monozygotic twins
-
Stark B, Jeison M, Preudhomme C, et al. Acquired trisomy 21 and distinct clonal evolution in acute megakaryoblastic leukaemia in young monozygotic twins. Br J Haematol. 2002;118: 1082-1086.
-
(2002)
Br J Haematol
, vol.118
, pp. 1082-1086
-
-
Stark, B.1
Jeison, M.2
Preudhomme, C.3
-
32
-
-
0030986775
-
Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome
-
Zipursky A, Brown E, Christensen H, Sutherland R, Doyle J. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome. Semin Perinatol. 1997;21:97-101.
-
(1997)
Semin Perinatol
, vol.21
, pp. 97-101
-
-
Zipursky, A.1
Brown, E.2
Christensen, H.3
Sutherland, R.4
Doyle, J.5
-
33
-
-
0033049402
-
Trisomy 8 as a secondary genetic change in acute megakaryoblastic leukemia associated with Down's syndrome
-
Ma SK, Lee AC, Wan TS, Lam CK, Chan LC. Trisomy 8 as a secondary genetic change in acute megakaryoblastic leukemia associated with Down's syndrome. Leukemia. 1999;13:491-492.
-
(1999)
Leukemia
, vol.13
, pp. 491-492
-
-
Ma, S.K.1
Lee, A.C.2
Wan, T.S.3
Lam, C.K.4
Chan, L.C.5
-
34
-
-
0035106116
-
Relationship between transient abnormal myelopoiesis and acute megakaryoblastic leukaemia in Down's syndrome
-
Ma SK, Wan TS, Chan GC, Ha SY, Fung LF, Chan LC. Relationship between transient abnormal myelopoiesis and acute megakaryoblastic leukaemia in Down's syndrome. Br J Haematol. 2001;112:824-825.
-
(2001)
Br J Haematol
, vol.112
, pp. 824-825
-
-
Ma, S.K.1
Wan, T.S.2
Chan, G.C.3
Ha, S.Y.4
Fung, L.F.5
Chan, L.C.6
-
35
-
-
0037100420
-
Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): A study of the Groupe Francais de Cytogenetique Hematologique (GFCH)
-
Dastugue N, Lafage-Pochitaloff M, Pages MP, et al. Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Francais de Cytogenetique Hematologique (GFCH). Blood. 2002;100:618-626.
-
(2002)
Blood
, vol.100
, pp. 618-626
-
-
Dastugue, N.1
Lafage-Pochitaloff, M.2
Pages, M.P.3
-
37
-
-
0036725138
-
A leukemogenic twist for GATA1
-
Look AT. A leukemogenic twist for GATA1. Nat Genet. 2002;32:83-84.
-
(2002)
Nat Genet
, vol.32
, pp. 83-84
-
-
Look, A.T.1
-
38
-
-
0035093813
-
Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia
-
Pabst T, Mueller BU, Zhang P, et al. Dominant-negative mutations of CEBPA, encoding CCAAT/ enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet. 2001;27: 263-270.
-
(2001)
Nat Genet
, vol.27
, pp. 263-270
-
-
Pabst, T.1
Mueller, B.U.2
Zhang, P.3
-
39
-
-
0036720398
-
The roles of FLT3 in hematopoiesis and leukemia
-
Gilliland DG, Griffin JD. The roles of FLT3 in hematopoiesis and leukemia. Blood. 2002;100: 1532-1542.
-
(2002)
Blood
, vol.100
, pp. 1532-1542
-
-
Gilliland, D.G.1
Griffin, J.D.2
|